Cumberland Pharmaceuticals, Inc. (CPIX) Tops Q3 EPS by 1c

Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q3 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $12.5 million versus the consensus estimate of $13.05 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals, Inc. (CPIX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus